A subscription to JoVE is required to view this content. Sign in or start your free trial.
Here, we present an alternative protocol to actively induce experimental autoimmune encephalomyelitis in C57BL/6 mice, using the immunogenic epitope myelin oligodendrocyte glycoprotein (MOG)35-55 suspended in incomplete Freund's adjuvant containing the heat-killed Mycobacterium avium subspecies paratuberculosis.
Experimental autoimmune encephalomyelitis (EAE) induced by myelin oligodendrocyte glycoprotein (MOG) requires immunization by a MOG peptide emulsified in complete Freund's adjuvant (CFA) containing inactivated Mycobacterium tuberculosis. The antigenic components of the mycobacterium activate dendritic cells to stimulate T-cells to produce cytokines that promote the Th1 response via toll-like receptors. Therefore, the amount and species of mycobacteria present during the antigenic challenge are directly related to the development of EAE. This methods paper presents an alternative protocol to induce EAE in C57BL/6 mice using a modified incomplete Freund's adjuvant containing the heat-killed Mycobacterium avium subspecies paratuberculosis strain K-10.
M. paratuberculosis, a member of the Mycobacterium avium complex, is the causative agent of Johne's disease in ruminants and has been identified as a risk factor for several human T-cell-mediated disorders, including multiple sclerosis. Overall, mice immunized with Mycobacterium paratuberculosis showed earlier onset and greater disease severity than mice immunized with CFA containing the strain of M. tuberculosis H37Ra at the same doses of 4 mg/mL. The antigenic determinants of Mycobacterium avium subspecies paratuberculosis (MAP) strain K-10 were able to induce a strong Th1 cellular response during the effector phase, characterized by significantly higher numbers of T-lymphocytes (CD4+ CD27+), dendritic cells (CD11c+ I-A/I-E+), and monocytes (CD11b+ CD115+) in the spleen compared to mice immunized with CFA. Furthermore, the proliferative T-cell response to the MOG peptide appeared to be highest in M. paratuberculosis-immunized mice. The use of an encephalitogen (e.g., MOG35-55) emulsified in an adjuvant containing M. paratuberculosis in the formulation may be an alternative and validated method to activate dendritic cells for priming myelin epitope-specific CD4+ T-cells during the induction phase of EAE.
Experimental autoimmune encephalomyelitis (EAE) is a common model for the study of human demyelinating disorders1. There are several models of EAE: active immunization using different myelin peptides in combination with potent adjuvants, passive immunization by in vitro transfer of myelin-specific CD4+ lymphocytes, and transgenic models of spontaneous EAE2. Each of these models has specific features that allow different aspects of EAE to be studied, such as the onset, effector phase, or chronic phase. The myelin oligodendrocyte glycoprotein (MOG) model of EAE is a good model to study the immune-mediat....
All mouse experiments were approved by the Institutional Animal Care and Use Committee of the Juntendo University School of Medicine (Approval Number 290238) and were conducted in accordance with the National Institutes of Health Guidelines for Animal Experimentation.
1. General comments on the experiment
Groups of C57BL/6 mice (total n = 15/group) were immunized with MOG35-55 in an emulsion containing M. paratuberculosis or by the common method with CFA. All groups of mice manifested an acute monophasic disease characterized by a single peak of disability observed at 14-17 days, followed by a partial recovery of symptoms over the next 10 days (Figure 1A). Mice immunized with the adjuvant containing M. paratuberculosis, irrespectiv.......
We demonstrated a robust alternative protocol to actively induce severe EAE in C57BL/6J mice using the peptide MOG35-55 emulsified in an adjuvant containing M. paratuberculosis10. The induction of EAE by this method resulted in a more severe disease than that induced by the common protocol with CFA. This difference could be due to the different lipidic components in the cell wall of the mycobacteria11. In fact, unlike other mycobacteria, M. paratuber.......
This work received support from a grant from the Japanese Society for the promotion of Science (grant no. JP 23K14675).
....Name | Company | Catalog Number | Comments |
anti-mouse CD115 antibody | Biolegend, USA | 135505 | for cytofluorimetry 1:1,000 |
anti-mouse CD11b antibody | Biolegend, USA | 101215 | for cytofluorimetry 1:1,000 |
anti-mouse CD11c antibody | Biolegend, USA | 117313 | for cytofluorimetry 1:1,000 |
anti-mouse CD16/32 antibody | Biolegend, USA | 101302 | for cytofluorimetry 1:1,000 |
anti-mouse CD4 antibody | Biolegend, USA | 116004 | for cytofluorimetry 1:1,000 |
anti-mouse CD8a antibody | Biolegend, USA | 100753 | for cytofluorimetry 1:1,000 |
anti-mouse I-A/I-E antibody | Biolegend, USA | 107635 | for cytofluorimetry 1:1,000 |
anti-mouse Ly-6C antibody | Biolegend, USA | 128023 | for cytofluorimetry 1:1,000 |
BBL Middlebrook OADC Enrichment | Thermo Fisher Scientific, USA | BD 211886 | for isolation and cultivation of mycobacteria |
C57BL/6J mice | Charles River Laboratory, Japan | 3 weeks old, male and female | |
FBS 10279-106 | Gibco Life Techologies, USA | 42F9155K | for cell culture, warm at 37 °C before use |
Freeze Dryer machine | Eyela, Tokyo, Japan | FDU-1200 | for bacteria lyophilization |
incomplete e Freund’s adjuvant | Difco Laboratories, MD, USA | 263810 | for use in adjuvant |
Middlebrook 7H9 Broth | Difco Laboratories, MD, USA | 90003-876 | help in the growth of Mycobacteria |
Mycobacterium avium subsp. paratuberculosis K-10 | ATCC, USA | BAA-968 | bacteria from bovine origin |
Mycobacterium tuberculosis H37 Ra, Desiccated | BD Biosciences, USA | 743-26880-EA | for use in adjuvant |
Mycobactin J | Allied Laboratory, MO, USA | growth promoter | |
Myelin Oligodendrocyte Glycolipid (MOG) 35-55 | AnaSpec, USA | AS-60130-10 | encephalotigenic peptide |
Ovalbumin (257-264) | Sigma-Aldrich, USA | S7951-1MG | negative control antigen for proliferative assay |
pertussis toxin solution | Fujifilm Wako, Osaka Japan | 168-22471 | From gram-negative bacteria Bordetella pertussi, increases blood-brain barrier permeability |
Polytron homogenizer PT 3100 | Kinematica | for mixing the antigen with the adjuvant | |
RPMI 1640 with L-glutamine | Gibco Life Techologies, USA | 11875093 | For cell culture |
Thymidine, [Methyl-3H], in 2% ethanol, 1 mCi | PerkinElmer, Waltham, MA, USA | NET027W001MC | for proliferation assay, use (1 μCi/well) |
Zombie NIR Fixable Viability Kit | Biolegend, USA | 423105 | cytofluorimetry, for cell viability |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved